ENDP: ENDO PHARMACEUTICALS HLDGS I Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 4 hrs, 43 mins

Symbol	Value	Change	Percentage Change
DJIA	10,023.42	17.46	0.17%
NASDAQ	2,112.44	7.12	0.34%
S&P 500	1,069.30	2.67	0.25%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

ENDO PHARMACEUTICALS HLDGS I

ENDP

Stock price

23.00 0.11 0.48%

as of 04:00 PM EST on 11/06/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

22.9054 -0.0946 -0.41%

as of 04:12 PM EST on 11/06/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ENDP

ENDO PHARMACEUTICALS HLDGS I Real-Time Headlines

Customize
Friday, November 6, 2009

Endo Pharma management to meet with RBC Capital

11/6/09 | Theflyonthewall.com

Wednesday, November 4, 2009

SEC Filing: Current Event

11/4/09 | Thomson Financial

Friday, October 30, 2009

Testosterone Is Sure Looking Virile

10/30/09 | BusinessWeek

Endo Pharmaceuticals Holdings Inc. Reports Operating Results (10-Q)

10/30/09 | GuruFocus

SEC Filing: Quarterly Financials

10/30/09 View all Related Articles > | Thomson Financial

Thursday, October 29, 2009

Endo Pharma Holdings Q3 Profit Decreases; Raises FY09 Guidance - Update

10/29/09 View all Related Articles > | RTTNews

Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance

10/29/09 | Investor's Business Daily

Endo Pharma reports Q3 EPS ex-items 63c vs. consensus of 65c

10/29/09 | Theflyonthewall.com

Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance

10/29/09 | PR Newswire

Thursday, October 22, 2009

SEC Filing: Current Event

10/22/09 | Thomson Financial

Monday, October 19, 2009

10/19 - Endo Pharmaceuticals Gives Update on Regulatory Status of FORT ...

10/19/09 View all Related Articles > | Pharmacy Choice

Endo Pharmaceuticals receives complete response letter from FDA

10/19/09 | Theflyonthewall.com

Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)

10/19/09 | PR Newswire

Thursday, October 15, 2009

D.E. Shaw lowers Endo Pharmaceuticals stake to 7.1% from 8.2%

10/15/09 | Theflyonthewall.com

SEC Filing: Acquisition Statement

10/15/09 | Thomson Financial

Thursday, October 8, 2009

Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

10/8/09 View all Related Articles > | Investor's Business Daily

Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

10/8/09 | PR Newswire

Tuesday, October 6, 2009

Stocks Showing Unusually Heavy Volume - CIENA Corp, Endo Pharmaceuticals, Yum! Brands Inc, Power-One Inc

10/6/09 View all Related Articles > | Schaeffer's Trading Floor Blog

Monday, October 5, 2009

SEC Filing: Current Event

10/5/09 | Thomson Financial

CAT: Analysts' Upgrades, Downgrades

10/5/09 | TheStreet.com

Oppenheimer Upgrades Endo Pharmaceuticals (ENDP) to Outperform

10/5/09 View all Related Articles > | StreetInsider.com

Endo Pharma upgraded at Oppenheimer

10/5/09 | Theflyonthewall.com

Friday, October 2, 2009

Endo Pharma coverage assumed with a Buy from Hold at Jefferies

10/2/09 | Theflyonthewall.com

Thursday, October 1, 2009

SEC Filing: Insider Buy/Sell

10/1/09 View all Related Articles > | Thomson Financial

Friday, September 25, 2009

09/25 - Endo Pharmaceuticals Announces Expiration of Cash Tender Offer ...

9/25/09 View all Related Articles > | Pharmacy Choice

Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes

9/25/09 | PR Newswire

Friday, September 18, 2009

A 25% Stock Gain Will Ease Any Pain

9/18/09 | The Motley Fool

Thursday, September 10, 2009

SEC Filing: Current Event

9/10/09 | Thomson Financial

Tuesday, September 8, 2009

SADIF Analytics releases new summary due diligence report for Endo Pharmaceuticals

9/8/09 | PR-inside - Austria

Thursday, September 3, 2009

Endo Pharmaceuticals Says FDA Extends Review Date for Testosterone Treatment

9/3/09 View all Related Articles > | Pharm Country

Don't Fret Over Allos Weakness: BioBuzz

9/3/09 | TheStreet.com

Endo Pharmaceuticals Says FDA Extends Review Date for Testosterone Treatment

9/3/09 | BioSpace

Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer

9/3/09 | PR Newswire

Elan, Biogen Head to Court Over Tysabri: BioBuzz

9/3/09 | TheStreet.com

Endo Pharmaceuticals Gives Update On Regulatory Status Of Testosterone Undecanoate For Men With Hypogonadism

9/3/09 View all Related Articles > | MediLexicon

Wednesday, September 2, 2009

Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism

9/2/09 | PR Newswire

Tuesday, September 1, 2009

FDA, Genzyme Spar in Cancer Drug Review

9/1/09 | TheStreet.com

Endo Drug Faces FDA Decision Wednesday

9/1/09 | TheStreet.com

Monday, August 31, 2009

Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009

8/31/09 | PR Newswire

SEC Filing: Current Event

8/31/09 View all Related Articles > | Thomson Financial

1 <Next>
Friday, November 6, 2009

Endo Pharma management to meet with RBC Capital

11/6/09 | Theflyonthewall.com

Wednesday, November 4, 2009

SEC Filing: Current Event

11/4/09 | Thomson Financial

Friday, October 30, 2009

Testosterone Is Sure Looking Virile

10/30/09 | BusinessWeek

Endo Pharmaceuticals Holdings Inc. Reports Operating Results (10-Q)

10/30/09 | GuruFocus

SEC Filing: Quarterly Financials

10/30/09 View all News Related Articles > | Thomson Financial

Thursday, October 29, 2009

Endo Pharma Holdings Q3 Profit Decreases; Raises FY09 Guidance - Update

10/29/09 View all News Related Articles > | RTTNews

Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance

10/29/09 | Investor's Business Daily

Endo Pharma reports Q3 EPS ex-items 63c vs. consensus of 65c

10/29/09 | Theflyonthewall.com

Thursday, October 22, 2009

SEC Filing: Current Event

10/22/09 | Thomson Financial

Monday, October 19, 2009

Endo Pharma Gets Complete Reponse Letter On Fortesta Testosterone Gel From FDA - Update

10/19/09 View all News Related Articles > | RTTNews

Endo Pharmaceuticals receives complete response letter from FDA

10/19/09 | Theflyonthewall.com

Thursday, October 15, 2009

D.E. Shaw lowers Endo Pharmaceuticals stake to 7.1% from 8.2%

10/15/09 | Theflyonthewall.com

SEC Filing: Acquisition Statement

10/15/09 | Thomson Financial

Thursday, October 8, 2009

Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

10/8/09 | Investor's Business Daily

Tuesday, October 6, 2009

Stocks Showing Unusually Heavy Volume - CIENA Corp, Endo Pharmaceuticals, Yum! Brands Inc, Power-One Inc

10/6/09 | Schaeffer's Investment Research

Monday, October 5, 2009

SEC Filing: Current Event

10/5/09 | Thomson Financial

CAT: Analysts' Upgrades, Downgrades

10/5/09 | TheStreet.com

Endo Pharma upgraded at Oppenheimer

10/5/09 | Theflyonthewall.com

Endo Pharma upgraded to Outperform from Perform at Oppenheimer

10/5/09 | Theflyonthewall.com

Friday, October 2, 2009

Endo Pharma coverage assumed with a Buy from Hold at Jefferies

10/2/09 | Theflyonthewall.com

Thursday, October 1, 2009

SEC Filing: Insider Buy/Sell

10/1/09 View all News Related Articles > | Thomson Financial

Friday, September 25, 2009

Endo Pharmaceuticals tenders $48 million in notes

9/25/09 | AP ONLINE

Friday, September 18, 2009

A 25% Stock Gain Will Ease Any Pain

9/18/09 | The Motley Fool

Thursday, September 10, 2009

SEC Filing: Current Event

9/10/09 | Thomson Financial

Thursday, September 3, 2009

Don't Fret Over Allos Weakness: BioBuzz

9/3/09 | TheStreet.com

Elan, Biogen Head to Court Over Tysabri: BioBuzz

9/3/09 | TheStreet.com

Wednesday, September 2, 2009

FDA extends review of Endo drug by 3 months

9/2/09 | AP ONLINE

Tuesday, September 1, 2009

FDA, Genzyme Spar in Cancer Drug Review

9/1/09 | TheStreet.com

Endo Drug Faces FDA Decision Wednesday

9/1/09 | TheStreet.com

Monday, August 31, 2009

SEC Filing: Current Event

8/31/09 View all News Related Articles > | Thomson Financial

Friday, August 28, 2009

Today's 5-Star Movers

8/28/09 | The Motley Fool

Endo Buys US Rights to Fortesta - Analyst Blog

8/28/09 | Zacks Investment Research

SEC Filing: Acquisition Statement

8/28/09 | Thomson Financial

Wednesday, August 26, 2009

Endo offers to buy notes to cut interest costs

8/26/09 | AP ONLINE

Endo buys testosterone product for up to $210M

8/26/09 | AP ONLINE

Wednesday, August 19, 2009

Three Sectors for the Downturn

8/19/09 | TheStreet.com

Tuesday, August 18, 2009

Biotech Calendar: Key Dates and Events

8/18/09 | TheStreet.com

Monday, August 17, 2009

SEC Filing: Current Event

8/17/09 | Thomson Financial

Friday, August 14, 2009

The Real King of the Drug Pushers

8/14/09 | The Motley Fool

Baytex, Chubb, Gentiv: Ratings Changes

8/14/09 | TheStreet.com

1 <Next>
Thursday, October 29, 2009

10/29 - Endo Pharmaceuticals Reports Third Quarter 2009 Financial Resu ...

10/29/09 View all Trade Related Articles > | Pharmacy Choice

Monday, October 19, 2009

10/19 - Endo Pharmaceuticals Gives Update on Regulatory Status of FORT ...

10/19/09 View all Trade Related Articles > | Pharmacy Choice

Thursday, October 8, 2009

Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

10/8/09 | StockWatch

Friday, September 25, 2009

09/25 - Endo Pharmaceuticals Announces Expiration of Cash Tender Offer ...

9/25/09 | Pharmacy Choice

Tuesday, September 8, 2009

SADIF Analytics releases new summary due diligence report for Endo Pharmaceuticals

9/8/09 | PR-inside - Austria

Thursday, September 3, 2009

Endo Pharmaceuticals Says FDA Extends Review Date for Testosterone Treatment

9/3/09 View all Trade Related Articles > | Pharm Country

Endo Pharmaceuticals Says FDA Extends Review Date for Testosterone Treatment

9/3/09 | BioSpace

Endo Pharmaceuticals Gives Update On Regulatory Status Of Testosterone Undecanoate For Men With Hypogonadism

9/3/09 View all Trade Related Articles > | MediLexicon

Thursday, August 27, 2009

Endo Pharmaceuticals Announces Cash Tender Offer For Any And All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes

8/27/09 View all Trade Related Articles > | Pharmaceutical Online

Wednesday, August 26, 2009

08/26 - Endo Pharmaceuticals Announces Cash Tender Offer for Any and A ...

8/26/09 View all Trade Related Articles > | Pharmacy Choice

ProStrakan Group Signs Deal with Endo Pharmaceuticals for up to $210 Million

8/26/09 View all Trade Related Articles > | Pharm Country

Tuesday, August 18, 2009

Biotech 2009 to Feature Endo Pharmaceuticals President and CEO, David P. Holveck, as Dinner Keynote Speaker

8/18/09 View all Trade Related Articles > | PharmaLive

Wednesday, August 12, 2009

Endo Pharmaceuticals Announces Resignation of Chief Operating Officer

8/12/09 View all Trade Related Articles > | Pharm Country

Thursday, July 30, 2009

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

7/30/09 View all Trade Related Articles > | StockWatch

Monday, July 13, 2009

Bioniche, Endo Pharmaceuticals Sign Licensing Agreement For Urocidin

7/13/09 | Pharmaceutical Business Review Online - UK

Friday, July 10, 2009

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM); Will Pay $20 Million Upfront and up to $110 Million

7/10/09 View all Trade Related Articles > | BioSpace

Thursday, June 11, 2009

Jubilant to Work With Endo Pharmaceuticals on Drug Development

6/11/09 View all Trade Related Articles > | The Pink Sheet Daily

Tuesday, June 9, 2009

Endo Pharmaceuticals Grants Valeant Pharmaceuticals International License to Market Pain Drug

6/9/09 View all Trade Related Articles > | Pharm Country

Friday, June 5, 2009

Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference

6/5/09 View all Trade Related Articles > | The Pink Sheet Daily

Friday, May 8, 2009

Endo Pharmaceuticals appoints former Pfizer, Moksha8 exec to EVP, CFO

5/8/09 | Drug Store News

Thursday, May 7, 2009

Endo Pharmaceuticals Appoints Alan G. Levin as Chief Financial Officer

5/7/09 | PharmaLive

Wednesday, April 29, 2009

Endo Pharmaceuticals Reports First Quarter 2009 Financial Results

4/29/09 View all Trade Related Articles > | PharmaLive

Endo Pharmaceuticals (ENDP) Release: Testosterone Undecanoate Achieves And Maintains Normal Testosterone Levels In Hypogonadal Men With Five Injections Per Year, New Data Show

4/29/09 View all Trade Related Articles > | Biocompare

Wednesday, April 8, 2009

Endo Pharmaceuticals to Announce First Quarter 2009 Financial Results on April 29, 2009

4/8/09 View all Trade Related Articles > | The Pink Sheet Daily

Monday, March 30, 2009

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

3/30/09 View all Trade Related Articles > | StockWatch

Wednesday, March 25, 2009

Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009

3/25/09 View all Trade Related Articles > | The Pink Sheet Daily

Tuesday, March 24, 2009

Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals, Inc.

3/24/09 View all Trade Related Articles > | Pharm Country

Monday, March 23, 2009

Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals

3/23/09 View all Trade Related Articles > | StockWatch

Thursday, March 19, 2009

Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals

3/19/09 View all Trade Related Articles > | PharmaLive

Friday, March 13, 2009

FDA Accepts Endo Pharmaceuticals (ENDP)'s Complete Response Submission to New Drug Application for NEBIDO(R)

3/13/09 View all Trade Related Articles > | Biocompare

Monday, March 2, 2009

Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals

3/2/09 View all Trade Related Articles > | PharmaLive

Friday, February 27, 2009

Endo Pharmaceuticals Net Jumps on Pain Drug, Generic Sales

2/27/09 View all Trade Related Articles > | Pharm Country

Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT Corporation

2/27/09 View all Trade Related Articles > | Pharm Country

Thursday, February 26, 2009

Endo Pharmaceuticals Appoints William Montague to Board of Directors

2/26/09 View all Trade Related Articles > | PharmaLive

Monday, February 23, 2009

Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period

2/23/09 | The Pink Sheet Daily

Thursday, February 12, 2009

Endo Pharmaceuticals (ENDP) Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments

2/12/09 | Biocompare

Tuesday, February 10, 2009

Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments

2/10/09 View all Trade Related Articles > | The Pink Sheet Daily

Tuesday, February 3, 2009

Endo Pharmaceuticals terminates research collaboration with Alexza

2/3/09 View all Trade Related Articles > | Pharmaceutical Business Review Online - UK

Monday, February 2, 2009

Endo Pharmaceuticals (ENDP) And Alexza Pharmaceuticals, Inc. (ALXA) Conclude Research Collaboration

2/2/09 | Biocompare

Friday, January 30, 2009

Endo Pharmaceuticals terminates research collaboration with Alexza

1/30/09 View all Trade Related Articles > | Datamonitor

1 <Next>
Thursday, January 29, 2009

Endo Pharmaceuticals and Alexza end collaboration

1/29/09 | Philadelphia Business Journal - Philadelphia PA

Friday, May 2, 2008

Ahead of the Bell: Endo Pharmaceuticals downgraded to 'Hold'

5/2/08 | The Boston Globe - Boston MA

Friday, February 22, 2008

Endo Pharmaceuticals raises 2008 guidance on better-than-expected 4th-quarter sales

2/22/08 View all Regional Related Articles > | CBS - WJZ 13 - Baltimore MD

Thursday, October 4, 2007

Shares of Endo Pharmaceuticals, Penwest Pharmaceuticals fall on patent challenge to pain drug

10/4/07 View all Regional Related Articles > | CBS 4 - Miami FL

Monday, October 1, 2007

Endo Pharmaceuticals shares fall as FDA denies additional Frova approval

10/1/07 View all Regional Related Articles > | CBS 5 KPIX - San Francisco CA

1
Thursday, October 29, 2009

Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance

10/29/09 | PR Newswire

Monday, October 19, 2009

Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)

10/19/09 | PR Newswire

Thursday, October 8, 2009

Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

10/8/09 | PR Newswire

Friday, September 25, 2009

Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes

9/25/09 | PR Newswire

Thursday, September 3, 2009

Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer

9/3/09 | PR Newswire

Wednesday, September 2, 2009

Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism

9/2/09 | PR Newswire

Monday, August 31, 2009

Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009

8/31/09 | PR Newswire

Wednesday, August 26, 2009

Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.

8/26/09 | PR Newswire

Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes

8/26/09 | PR Newswire

Tuesday, August 18, 2009

Biotech 2009 to Feature Endo Pharmaceuticals President and CEO, David P. Holveck, as Dinner Keynote Speaker

8/18/09 | Business Wire

Wednesday, August 12, 2009

Endo Pharmaceuticals Announces Resignation of Chief Operating Officer

8/12/09 | PR Newswire

Thursday, July 30, 2009

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

7/30/09 | PR Newswire

Friday, July 10, 2009

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

7/10/09 | PR Newswire

Wednesday, July 1, 2009

Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009

7/1/09 | PR Newswire

Notable Option Volume in KLA-Tencor Corporation (KLAC) and Endo Pharmaceuticals (ENDP) - www.ONN.tv Reports

7/1/09 | PR Newswire

Thursday, June 11, 2009

Jubilant to Work With Endo Pharmaceuticals on Drug Development

6/11/09 | PR Newswire

Wednesday, June 10, 2009

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

6/10/09 | PR Newswire

Friday, June 5, 2009

Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference

6/5/09 | PR Newswire

Friday, May 29, 2009

Endo Announces Compensation for New CFO Alan Levin

5/29/09 | PR Newswire

Friday, May 8, 2009

Zacks Analyst Blog Highlights: General Motors Corp., Durect Corp., Endo Pharmaceuticals, Onyx Pharmaceuticals and Supertex Inc.

5/8/09 | Business Wire

Thursday, May 7, 2009

Endo Pharmaceuticals Appoints Alan G. Levin as Chief Financial Officer

5/7/09 | PR Newswire

Wednesday, May 6, 2009

Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference

5/6/09 | PR Newswire

Wednesday, April 29, 2009

Endo Pharmaceuticals Reports First Quarter 2009 Financial Results

4/29/09 | PR Newswire

Tuesday, April 28, 2009

Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show

4/28/09 | PR Newswire

Wednesday, April 8, 2009

Endo Pharmaceuticals to Announce First Quarter 2009 Financial Results on April 29, 2009

4/8/09 | PR Newswire

Tuesday, April 7, 2009

Zacks Releases New Stock Picks from the +21.7% Value Strategy: ADAM Inc., Big Lots, Endo Pharmaceuticals, Carrols Restaurant Group and Gray Television

4/7/09 | Business Wire

Monday, March 30, 2009

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

3/30/09 | PR Newswire

Wednesday, March 25, 2009

Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009

3/25/09

Live Updates:

Ticker

Dynamic view of the market

ENDO PHARMACEUTICALS HLDGS I

ENDP

Stock price

Extended Hours

ENDO PHARMACEUTICALS HLDGS I Real-Time Headlines

Friday, November 6, 2009

Wednesday, November 4, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Thursday, October 22, 2009

Monday, October 19, 2009

Thursday, October 15, 2009

Thursday, October 8, 2009

Tuesday, October 6, 2009

Monday, October 5, 2009

Friday, October 2, 2009

Thursday, October 1, 2009

Friday, September 25, 2009

Friday, September 18, 2009

Thursday, September 10, 2009

Tuesday, September 8, 2009

Thursday, September 3, 2009

Wednesday, September 2, 2009

Tuesday, September 1, 2009

Monday, August 31, 2009

Friday, November 6, 2009

Wednesday, November 4, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Thursday, October 22, 2009

Monday, October 19, 2009

Thursday, October 15, 2009

Thursday, October 8, 2009

Tuesday, October 6, 2009

Monday, October 5, 2009

Friday, October 2, 2009

Thursday, October 1, 2009

Friday, September 25, 2009

Friday, September 18, 2009

Thursday, September 10, 2009

Thursday, September 3, 2009

Wednesday, September 2, 2009

Tuesday, September 1, 2009

Monday, August 31, 2009

Friday, August 28, 2009

Wednesday, August 26, 2009

Wednesday, August 19, 2009

Tuesday, August 18, 2009

Monday, August 17, 2009

Friday, August 14, 2009

Thursday, October 29, 2009

Monday, October 19, 2009

Thursday, October 8, 2009

Friday, September 25, 2009

Tuesday, September 8, 2009

Thursday, September 3, 2009

Thursday, August 27, 2009